drug discovery

2 articles

AI Co-Scientists: How Autonomous Research Agents Are Redefining Scientific Discovery

A new class of AI systems — termed 'Co-Scientists' — is emerging to function not as mere search tools, but as active research collaborators capable of forming hypotheses, designing experiments, and synthesizing multi-domain literature. These systems, pioneered by labs including Google DeepMind, represent a structural shift in how foundational science gets done. Decision-makers in biotech, pharma, and deep-tech must now assess whether AI co-authorship is a competitive edge or an existential baseline.

Jun 4Read →

AI Research

AlphaFold at the Nobel Frontier Again: Can DeepMind's AI Win Science's Highest Honor Twice?

DeepMind's AlphaFold system, which already secured a Nobel Prize in Chemistry in 2024 for its revolutionary protein structure prediction capabilities, is generating renewed Nobel buzz as AlphaFold3 extends its predictive reach to DNA, RNA, and molecular interactions. The scientific community is debating whether successive breakthroughs from a single AI platform can — or should — earn repeated recognition from the Nobel Committee. This conversation marks a defining moment in the institutionalization of AI-driven scientific discovery.

Jun 4Read →